Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 26, 2026
Synthesis and biological evaluation of benzyloxymethyl-substituted imidazo[1,2-a]pyridines as apoptosis-inducing anticancer agents through modulation of BCL-2/Bax signaling and caspase-3 activationEge Arzuk, İbrahim Pinar, Burak Kuzu
Cancer Medicine|May 15, 2025
In Silico Network Toxicology, Molecular Docking, and Multi-Level Bioinformatics Reveal Methyl Eugenol-Induced Hepatocellular Carcinoma Mechanisms in HumansFuat Karakuş, Zübeyde Tanrıverdi, Burak Kuzu
Journal of Biomolecular Structure & Dynamics|November 14, 2024
New targets and biomarkers for doxorubicin-induced cardiotoxicity in humans: implications drawn from toxicogenomic data and molecular modellingFuat Karakuş, Abdulilah Ece, Burak Kuzu
Drug and Chemical Toxicology|August 21, 2024
Screening and toxicity evaluation of natural compounds as adenosine 2a and 2b receptor ligands: insights from molecular docking, dynamics, and ADMET analysisFuat Karakuş, Mehmet Abdullah Alagöz, Burak Kuzu
Chemistry & Biodiversity|November 25, 2025
Synthesis of New Pyrazolo[1,5-a]Pyrazin-4(5H)-One Derivatives and Effects on PI3K Protein Levels in A549 Lung Adenocarcinoma Cell LineBurak Kuzu, Ege Arzuk, Meltem Tan-Uygun
Journal of Fluorescence|March 27, 2021
Excited State Intramolecular Proton Transfer (ESIPT)-Based Sensor for Ion DetectionBurak Kuzu, Zeynep Ekmekci, Meltem Tan, et al.
Current Computer-Aided Drug Design|May 29, 2024
Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity PredictionFuat Karakuş, Burak Kuzu, Sedat Köstekci, et al.
Archiv Der Pharmazie|June 7, 2021
A novel class for carbonic anhydrases inhibitors and evaluation of their non-zinc bindingBurak Kuzu, Meltem Tan, İlhami Gülçin, et al.
Chemical Biology & Drug Design|March 13, 2025
Pyrrole-Tethered Bisbenzoxazole Derivatives: Apoptosis-Inducing Agents Targeting Breast Cancer CellsBurak Kuzu, Derya Yetkin, Ceylan Hepokur, et al.
Archiv Der Pharmazie|October 13, 2025
Innovative Pyrazole-Thiazole-Oxadiazole Hybrid Compounds for Targeted EGFR/VEGFR2 Inhibition in Cancer TreatmentBurak Kuzu, Derya Osmaniye, Abdullah Burak Karaduman, et al.
Pageof 4